DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs-Reference-Cited by-同舟云学术

DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs

Published:2019-05-09 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zhang Jianqiang,Chen Qiuyue,Zhong Jixin,Liu Chaohong,Zheng Bing,Gong Quan

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hubei Province

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference125 articles.

1. Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function;Gong;Int J Cardiol.,2015

2. Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin;White;Hypertension.,2016

3. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus;Scirica;N Engl J Med,2013

4. Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: a pilot study;Leung;Diab Vasc Dis Res.,2016

5. Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease;Kato;Int J Cardiol.,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure;World Journal of Cardiology;2024-08-26

2. Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation;Pharmaceutics;2024-02-16

3. Biomarkers in inflammatory bowel disease: a practical guide;Therapeutic Advances in Gastroenterology;2024-01

4. An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches;Current Diabetes Reviews;2024-01

5. Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study;Physiological Reports;2023-06